Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
JAMA Network Open|August 27, 2024
Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate CancerDaniel J George, Alicia K Morgans, Niculae Constantinovici, et al.Prostate Cancer and Prostatic Diseases|March 19, 2026
Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT studyNeal D Shore, Daniel J George, Nasreen Khan, et al.Cancer Medicine|September 3, 2025
Treatment Landscape for Older Men With Metastatic Hormone-Sensitive Prostate Cancer in the United StatesBo Zhou, Amit D Raval, Yifan Zhang, et al.Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.Future Oncology (London, England)|April 1, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patientsRana R McKay, Ashley E Ross, Mark A Preston, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2006
Once-every-2-weeks and once-weekly epoetin beta regimens: equivalency in hemodialyzed patientsGabriel Mircescu, Liliana Gârneată, Alexandru Ciocâlteu, et al.Blood|May 3, 2015
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok, Antonis Kattamis, M Domenica Cappellini, et al.Prostate Cancer and Prostatic Diseases|February 22, 2022
Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)Daniel J George, Neeraj Agarwal, Oliver Sartor, et al.European Urology Open Science|April 4, 2024
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER PlatformPawel Rajwa, Angelika Borkowetz, Thomas Abbott, et al.Pageof 2